7-48171493-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_152701.5(ABCA13):c.10G>A(p.Ala4Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000309 in 1,536,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_152701.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCA13 | NM_152701.5 | c.10G>A | p.Ala4Thr | missense_variant | 1/62 | ENST00000435803.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCA13 | ENST00000435803.6 | c.10G>A | p.Ala4Thr | missense_variant | 1/62 | 1 | NM_152701.5 | P1 | |
ABCA13 | ENST00000417403.5 | c.10G>A | p.Ala4Thr | missense_variant, NMD_transcript_variant | 1/18 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000198 AC: 28AN: 141750Hom.: 0 AF XY: 0.000158 AC XY: 12AN XY: 75814
GnomAD4 exome AF: 0.000306 AC: 424AN: 1383820Hom.: 1 Cov.: 30 AF XY: 0.000290 AC XY: 198AN XY: 682844
GnomAD4 genome AF: 0.000335 AC: 51AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.10G>A (p.A4T) alteration is located in exon 1 (coding exon 1) of the ABCA13 gene. This alteration results from a G to A substitution at nucleotide position 10, causing the alanine (A) at amino acid position 4 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | ABCA13: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at